Home > Healthcare > Medical Devices > Implantable Devices > Biliary Stents Market

Biliary Stents Market Analysis

  • Report ID: GMI4034
  • Published Date: Dec 2022
  • Report Format: PDF

Biliary Stents Market Analysis

Biliary stents market size from polymer stent products is expected to register more than 5% CAGR through 2032. The robust product adoption is attributed to the usage of hydrophobic materials that are relatively inexpensive compared to their metal counterparts. Polymer stents placed in the bile duct also safeguard the protective barrier function of the sphincter of Oddi, through the prevention of bacteria formation in the biliary tract and the stent. Various other advantages of polymer stents, including easy removal, cost saving, and minimal hospital stay are also expected to boost product consumption.
 

Biliary stents market share from benign biliary structure applications is projected to be valued at more than USD 29 million by 2032. The strong need for these stents is attributed to the increasing prevalence of cancer, chronic illness, and liver disease. Also, the incidence rate of bile duct injury is approximately 0.2-0.3%, and close to 0.4-0.6% after an open cholecystectomy procedure. These aspects are anticipated to positively impact the industry trends.


Biliary Stents Market Share By End-use

Biliary stents market revenue from specialty clinics end-use segment is estimated to cross USD 26.5 million by 2032. The overall network of these clinics is growing at a notable rate across developed and developing nations, presenting significant treatment options to patients suffering from chronic ailments. Also, more patients, especially among the elderly population, are opting for minimally invasive surgical procedures as they cause minimal scarring and enhance patient outcomes. This will have a significant impact on the demand for endoscopic biliary stent surgeries, thereby bolstering product adoption in facilities such as specialty clinics.

Biliary Stents Market By Region

Latin America biliary stents market size is projected to depict more than 4.5% CAGR through 2032. The healthcare sector in the region is witnessing substantial growth due to heavy investments by governments in a wide range of innovative medical technologies. Several hospitals and ambulatory surgical centers in the region are being equipped with advanced diagnostic technologies, which will play a vital role in the development of the biliary stents industry in Latin America.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for biliary stents revenue surpassed USD 394.5 million in 2022 and is anticipated to record more than 5.5% CAGR over 2023-2032, due to the rising incidence of bile duct & liver cancers and gastrointestinal diseases.

Polymer biliary stents industry size is expected to register more than 5% CAGR through 2032, due to the widespread demand for hydrophobic materials that are more affordable as compared to their metal counterparts.

Latin America biliary stents market size is projected to depict more than 4.5% CAGR through 2032, given the rapid expansion of the healthcare sector and investments by governments in a wide range of innovative medical technologies.

Boston Scientific, Cook Group, ENDO-FLEX GmbH, Olympus Corporation, B Braun Melsungen, CONMED Corporation, M.I Tech, C.R. Bard (Becton, Dickinson & Company), Medtronic plc, Cardinal Health, and Merit Medical System, are a few of the prominent companies operating in biliary stents business.

Biliary Stents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 181
  • Countries covered: 17
  • Pages: 139
 Download Free Sample